JCI Insight Response to Reviewers: A Translational Revision Guide
A JCI Insight revision guide for aligning mechanism, model, patient cohort, statistical evidence, and the required marked-up response package.
Readiness scan
Find out if this manuscript is ready to submit.
Run the Free Readiness Scan before you submit. Catch the issues editors reject on first read.
How to use this page well
These pages work best when they behave like tools, not essays. Use the quick structure first, then apply it to the exact journal and manuscript situation.
Question | What to do |
|---|---|
Use this page for | Building a point-by-point response that is easy for reviewers and editors to trust. |
Start with | State the reviewer concern clearly, then pair each response with the exact evidence or revision. |
Common mistake | Sounding defensive or abstract instead of specific about what changed. |
Best next step | Turn the response into a visible checklist or matrix before you finalize the letter. |
Quick answer: A JCI Insight response to reviewers belongs at the front of the marked-up full-manuscript PDF. Cite every change by page and line, figure, table, Methods subsection, or supplement. Organize the scientific answer around the manuscript's translational chain: mechanism, disease model, patient relevance, cohort design, statistics, and claim boundary. JCI Insight requires all listed authors to approve the revision, so finish scientific reconciliation and coauthor sign-off before the upload deadline rather than treating approval as a clerical afterthought.
Start with a JCI Insight revision readiness scan. Use the JCI Insight submission guide for initial requirements, the JCI Insight under-review page for status questions, and the JCI Insight journal profile for broader routing.
The JCI Insight revised-submission package
The journal's revised-manuscript instructions specify a marked-up PDF of the entire manuscript prefaced by a point-by-point response. That design makes the response and revision one continuous verification document. The Author Information Center also states that all authors in the submission system must approve the revised submission before the Editorial Board can receive it.
Build the package around six linked checks:
Decision concern | Revised evidence | Consistency check |
|---|---|---|
Mechanism | Perturbation, rescue, temporal order, or pathway test | Abstract and model figure do not overstate causality |
Disease relevance | Phenotype, tissue context, or clinically meaningful endpoint | Discussion explains what the model does and does not represent |
Human translation | Patient cohort, specimen validation, or external dataset | Population and treatment context are stated precisely |
Statistics | Design, units, multiplicity, effect sizes, uncertainty | Figure legends and Methods use the same analysis |
Reagents and reporting | Antibody, construct, cell line, sequence, protocol detail | Supplement and resource identifiers are complete |
Revision audit | Point-by-point action plus exact location | Marked PDF visibly contains every promised change |
The response should tell the editor how the evidence chain changed, not only list edits.
Copyable JCI Insight response template
Use bold for editor and reviewer comments and regular text for your reply. In the marked-up manuscript, choose a visible convention that remains legible when printed.
Dear Editors,
Thank you for the opportunity to revise manuscript JCIINSIGHT-2026-0412,
"DUSP4 Loss Sustains RAS Signaling in Lung Adenocarcinoma." The decision
identified three central issues: whether MAPK signaling
is causal, whether the model reflects the human disease context, and
whether the cohort analysis supports the clinical interpretation. We
address those issues first and then respond point by point. Comments are
in bold; page and line numbers refer to the marked-up manuscript.
Editorial issue 1: Causal mechanism
Response: We added loss-of-function and rescue experiments that separate
DUSP4-dependent MAPK signaling from the correlated phenotype. The design
is on page 7, lines
5-21; results are in new Figure 4, and controls are in Figure S5. The
abstract now limits the claim to the tested DUSP4-dependent mechanism.
Reviewer 1, Comment 2
"The animal model does not establish relevance to the human disease."
Response: We agree that the original text crossed that boundary. We added
validation in 86 patient specimens, report cohort and treatment context
in Table 1, and revised the Discussion. See page 10, lines 8-31 and new
Figure 6. We no longer claim [unsupported clinical conclusion].
Reviewer 2, Comment 4
"The experimental unit and multiplicity correction are unclear."
Response: We now define the biological unit for every panel, distinguish
technical from biological replicates, and control the prespecified family
of comparisons using the Holm method. See Methods, page 15, lines 2-27,
and the
revised legends for Figures 2-5.
Reviewer 3, Comment 1
"The reagent specificity is not demonstrated."
Response: We added orthogonal validation and the requested negative
control. The evidence appears in Figure S3; reagent identifiers and the
validation protocol are on page 17, lines 11-30.
Sincerely,
Dr. A. Researcher, responsible party, on behalf of all authorsDo not promise a study that is still in progress. The response and marked-up manuscript should describe completed evidence only.
Cite page, line, panel, and manuscript component
Every response needs a page and line reference. For experiments, add the figure and panel; for analyses, add the table or statistical subsection; for resource concerns, add the reagent table or supplement.
Clinical and translational revisions propagate. If a cohort reanalysis changes an effect estimate, update the Results, figure, abstract, discussion, and any graphical summary. List all those locations in one response. A reviewer should not find the old estimate elsewhere in the marked PDF.
After compiling the final response-prefaced manuscript, verify the locations from that combined file. The response pages themselves can shift all later pagination if you cite the wrong PDF version.
Typography inside the combined marked PDF
Because the response precedes the marked manuscript, readers should see an immediate visual boundary between reviewer text and author response. Use bold or shaded reviewer blocks plus explicit labels. Keep author replies in regular text. Do not use red and green alone.
Within the manuscript, mark substantive additions consistently. A response that cites page 12 but leaves the new causal limitation visually indistinguishable from old text makes verification harder than it needs to be.
Translate each reviewer request into the uncertainty it tests
Reviewer request | Likely uncertainty | Evidence that answers it |
|---|---|---|
Add a rescue | Whether the perturbation acts through the claimed mechanism | Rescue with a construct or intervention specific to the pathway |
Add another model | Whether the result is model-specific | Orthogonal model chosen for the identified biological difference |
Validate in patients | Whether the signal exists in the disease population | Cohort with defined inclusion, treatment, tissue, and endpoint context |
Increase sample size | Precision, heterogeneity, or power | Design-aware expansion or uncertainty analysis targeted to the concern |
Reanalyze statistics | Unit, distribution, multiplicity, or confounding | Corrected model, effect size, interval, and sensitivity analysis |
Temper conclusions | Claim exceeds identification | Updated abstract, Results language, Discussion, and model figure |
Do not treat "another cohort" as a universal answer. A second convenience cohort may repeat the same selection bias and leave the translational concern untouched.
Tone calibration for JCI Insight revisions
Avoid | Better |
|---|---|
"The reviewer overlooked our mechanism data." | "We did not make the causal test visible. We added the rescue experiment in Figure 4 and rewrote page 7, lines 5-21." |
"A patient cohort is beyond the scope." | "The claim required human support. We added specimen validation and now limit the conclusion to the represented disease and treatment context." |
"The sample size is standard for the field." | "We report the effect size and interval, explain the available sample, and add a sensitivity analysis targeted to the precision concern." |
"Reviewer 2 agreed with our statistics." | "We revised the unit-of-analysis definition and multiplicity control in Methods and every affected legend." |
"All reagents are well established." | "We provide identifiers, orthogonal validation, and the negative control in Supplementary Figure S3." |
Another reviewer's silence is not evidence. Answer each scientific uncertainty on its own merits.
In our pre-submission review work with JCI Insight revisions
In our pre-submission review work with JCI Insight manuscripts and revisions, we test whether the response, marked manuscript, clean manuscript, figures, statistical outputs, and supplementary evidence tell one translational story. This is where generic point-by-point advice stops being useful: a gracious answer can still leave mechanism, model, patient evidence, and claim boundary misaligned. The observations below are anonymized Manusights patterns, not access to internal JCI Insight decisions or private editorial data. Each can be checked directly from an author's own files.
Mechanism claimed from parallel movement. In JCI Insight revisions, the perturbation and phenotype may change together, but no rescue, temporal test, or pathway-specific control separates cause from correlation. Authors add pathway discussion in the response while leaving the abstract's causal verb intact. We flag the verb first because that is where reviewers see the unresolved inference, then trace it through the model figure, Results, and Discussion.
Human relevance reduced to one expression plot. A JCI Insight disease-model result can be paired with a public dataset showing differential expression, then described as clinically validated. The cohort lacks treatment context, stage, tissue handling, or an endpoint aligned with the claim. A credible revision defines what the human evidence actually establishes and puts that boundary in the abstract and figure legend, not only in a limitation paragraph.
Experimental units that change by figure. Animals, wells, images, and cells are counted inconsistently. A revised Methods paragraph cannot repair confidence intervals derived from the wrong unit. The response must state which analyses were rerun and where every corrected result appears.
A supplementary repair with an unchanged narrative. Authors add controls to the supplement but do not alter the model figure, Results hierarchy, or conclusion. Returning reviewers compare the central story with the new evidence. If the repair narrows the mechanism, the narrative must narrow too.
Our final check asks whether a skeptical reader could reconstruct the revised inference from the Methods and figures without reading the rebuttal. If not, the response is carrying scientific content that belongs in the manuscript. That cross-file test regularly catches incomplete revisions that a checklist of comments would mark as done.
Review the JCI Insight response and revised translational chain together before all authors approve the package.
Reconciling comments across reviewers and editors
Create one issue ledger shared by all coauthors. Merge comments that target the same claim even if they ask for different experiments. An editor's concern about disease relevance, a reviewer's request for a patient cohort, and another reviewer's objection to the model may all point to one translational gap.
Choose one evidence plan, then reference the same plan from each answer. Contradictory replies are particularly visible in a combined response-and-manuscript PDF.
When to disagree with a requested experiment
Disagree when the experiment cannot identify the concern, would violate ethics or consent boundaries, or would imply a different study design. Explain the distinction and provide the closest valid evidence.
If a reviewer requests an intervention outcome from an observational cohort, do not imply causality from additional adjustment. Add the relevant sensitivity analysis, state the residual confounding, and remove treatment-effect language.
Where JCI Insight revisions fail
Most rejection-on-revision risk sits in unresolved central inference, not missing courtesy. A causal mechanism remains correlational, a model-to-patient leap remains unsupported, or a statistical correction changes the result without changing the claim. Those are scientific failures even when every response paragraph is polished.
A revision invitation is not an acceptance. If the new evidence no longer supports the original headline, revise the headline. Editors can work with a bounded conclusion; they cannot accept a response that conceals the boundary.
Submit if; think twice if
Submit if: the mechanism is tested rather than inferred from parallel change, the human cohort has explicit disease and treatment context, statistical units are consistent, and every revised claim is visible in the marked manuscript. All authors should have approved one frozen final package.
Think twice if: patient relevance rests on one decontextualized dataset, a causal verb survives without a discriminating experiment, or corrected statistics alter the result without altering the abstract. Resolve or narrow the translational claim before returning the revision.
Readiness check
Run the scan to see how your manuscript scores on these criteria.
See score, top issues, and what to fix before you submit.
Final JCI Insight response audit
- Put the Editors' controlling scientific issues first.
- Connect mechanism, model, patient evidence, and claim boundary.
- Define biological units, replicate types, effect sizes, and multiplicity.
- Supply reagent identifiers and validation where relevant.
- Reproduce every reviewer comment and answer in order.
- Cite page, line, figure, panel, table, Methods, and supplement locations.
- Make every promised change visible in the marked manuscript.
- Reconcile abstract, figures, Results, and Discussion after reanalysis.
- Obtain approval from every listed author before the deadline.
- Re-run a JCI Insight journal-fit check if the revision materially narrows the translational claim.
This page was last reviewed on July 12, 2026. Official JCI Insight sources control the submission mechanics; Manusights analysis provides the translational revision map.
Frequently asked questions
JCI Insight's revised-manuscript instructions require a PDF of the marked-up entire manuscript that begins with a point-by-point response to reviewer comments. Organize the response under the editor and each reviewer, reproduce every comment, state what changed, and cite the exact page, line, figure, table, or supplement.
Prioritize the scientific issues controlling the decision: causal mechanism, disease relevance, model-to-human translation, cohort design, statistical support, and whether the conclusion matches the evidence. Keep those changes synchronized across the response, marked-up manuscript, clean manuscript, figures, and supplementary material.
Yes. Restate the concern accurately, distinguish what the experiment can identify, provide the closest valid evidence, and narrow the claim where uncertainty remains. Avoid relying on reputation, precedent, or another reviewer's silence.
Yes. JCI Insight's Author Information Center states that all authors listed in the submission site must approve a revised submission before it can return to the Editorial Board. Build coauthor approval into the revision schedule rather than treating it as a final administrative step.
Sources
- 1. JCI Insight revised-manuscript submission instructions (accessed July 12, 2026)
- 2. JCI Insight Author Information Center (accessed July 12, 2026)
- 3. JCI/JCI Insight publication ethics and review process (accessed July 12, 2026)
- 4. Ten Simple Rules for Writing a Response to Reviewers, PLOS Computational Biology (accessed July 12, 2026)
- 5. How to respond to reviewers, Nature Computational Science (accessed July 12, 2026)
Final step
Find out if this manuscript is ready to submit.
Run the Free Readiness Scan. See score, top issues, and journal-fit signals before you submit.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Same journal, next question
- JCI Insight Submission Guide: What to Prepare Before You Submit
- How to Avoid Desk Rejection at JCI Insight (2026)
- JCI Insight Review Time: What Authors Can Actually Expect
- JCI Insight Impact Factor 2026: 6.8, Q1
- JCI Insight Submission Process: What Happens After You Upload
- Rejected from JCI Insight? The 7 Best Journals to Submit Next